Sino Biopharmaceutical Limited SBMFF Stock
Sino Biopharmaceutical Limited Price Chart
Sino Biopharmaceutical Limited SBMFF Financial and Trading Overview
| Sino Biopharmaceutical Limited stock price | 0.49 USD |
| Previous Close | 0.38 USD |
| Open | 0.38 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.38 - 0.38 USD |
| 52 Week Range | 0.32 - 0.63 USD |
| Volume | 100 USD |
| Avg. Volume | 566 USD |
| Market Cap | 8B USD |
| Beta (5Y Monthly) | 0.737 |
| PE Ratio (TTM) | 38.420002 |
| EPS (TTM) | 0.01 USD |
| Forward Dividend & Yield | 0.01 (2.66%) |
| Ex-Dividend Date | October 4, 2023 |
| 1y Target Est | N/A |
SBMFF Valuation Measures
| Enterprise Value | 9.42B USD |
| Trailing P/E | 38.420002 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.27703038 |
| Price/Book (mrq) | 0.23585023 |
| Enterprise Value/Revenue | 0.326 |
| Enterprise Value/EBITDA | 1.356 |
Trading Information
Sino Biopharmaceutical Limited Stock Price History
| Beta (5Y Monthly) | 0.737 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.63 USD |
| 52 Week Low | 0.32 USD |
| 50-Day Moving Average | 0.4 USD |
| 200-Day Moving Average | 0.45 USD |
SBMFF Share Statistics
| Avg. Volume (3 month) | 566 USD |
| Avg. Daily Volume (10-Days) | 140 USD |
| Shares Outstanding | 18.8B |
| Float | 9.35B |
| Short Ratio | N/A |
| % Held by Insiders | 48.13% |
| % Held by Institutions | 14.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.073 |
| Trailing Annual Dividend Yield | 19.00% |
| 5 Year Average Dividend Yield | 131.00% |
| Payout Ratio | 1.1144 |
| Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.51% |
| Operating Margin (ttm) | 20.45% |
| Gross Margin | 78.89% |
| EBITDA Margin | 24.07% |
Management Effectiveness
| Return on Assets (ttm) | 5.59% |
| Return on Equity (ttm) | 12.01% |
Income Statement
| Revenue (ttm) | 28.86B USD |
| Revenue Per Share (ttm) | 1.55 USD |
| Quarterly Revenue Growth (yoy) | 0.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 6.95B USD |
| Net Income Avi to Common (ttm) | 1.88B USD |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | -34.50% |
Balance Sheet
| Total Cash (mrq) | 15.68B USD |
| Total Cash Per Share (mrq) | 0.85 USD |
| Total Debt (mrq) | 11.55B USD |
| Total Debt/Equity (mrq) | 31.69 USD |
| Current Ratio (mrq) | 1.004 |
| Book Value Per Share (mrq) | 1.629 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.99B USD |
| Levered Free Cash Flow (ttm) | 5.33B USD |
Profile of Sino Biopharmaceutical Limited
| Country | United States |
| State | N/A |
| City | Wan Chai |
| Address | Unit 09, Office Tower |
| ZIP | N/A |
| Phone | 852 2802 9886 |
| Website | https://www.sinobiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26079 |
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Q&A For Sino Biopharmaceutical Limited Stock
What is a current SBMFF stock price?
Sino Biopharmaceutical Limited SBMFF stock price today per share is 0.49 USD.
How to purchase Sino Biopharmaceutical Limited stock?
You can buy SBMFF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sino Biopharmaceutical Limited?
The stock symbol or ticker of Sino Biopharmaceutical Limited is SBMFF.
Which industry does the Sino Biopharmaceutical Limited company belong to?
The Sino Biopharmaceutical Limited industry is Biotechnology.
How many shares does Sino Biopharmaceutical Limited have in circulation?
The max supply of Sino Biopharmaceutical Limited shares is 18.18B.
What is Sino Biopharmaceutical Limited Price to Earnings Ratio (PE Ratio)?
Sino Biopharmaceutical Limited PE Ratio is 49.40000000 now.
What was Sino Biopharmaceutical Limited earnings per share over the trailing 12 months (TTM)?
Sino Biopharmaceutical Limited EPS is 0.01 USD over the trailing 12 months.
Which sector does the Sino Biopharmaceutical Limited company belong to?
The Sino Biopharmaceutical Limited sector is Healthcare.